• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 (CD38), Truncated

Recombinant human ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 (CD38) production in mammalian cells involves co-cloning the gene encoding the extracellular domain of the human CD38 protein (43-300aa) into an expression vector with a C-terminal hFc-tag gene, followed by transformation into mammalian cells. The cells are cultured under conditions that induce protein expression. After sufficient growth, the cells are lysed to release the recombinant protein. Purification is achieved using affinity chromatography technique. The purity of the CD38 protein is confirmed using SDS-PAGE, reaching over 85%. Human CD38 protein is a transmembrane glycoprotein that stimulates B-lymphocyte activation and acts as an enzyme that catalyzes the synthesis of cyclic ADP-ribose from NAD+ [1]. It is a part of the ADP ribosyl cyclase/CD38 gene family and is evolutionarily conserved, indicating its importance in human physiology [2]. CD38 functions as an ectoenzyme and a receptor, degrading NAD and modulating cellular NAD homeostasis [3]. Furthermore, CD38 is involved in oxytocin secretion, social behavior, and calcium regulation [4][5]. It is expressed in inflammatory conditions and is robustly induced in human macrophages under inflammatory stimuli [6]. CD38 is also implicated in diseases like cancer, where it is methylated in prostate cancer and regulates extracellular NAD+ [7]. References:[1] M. Dong, Y. Qi, S. Sun, X. Pu, Z. Yang, L. Zhanget al., Design, synthesis and biological characterization of novel inhibitors of cd38, Organic & Biomolecular Chemistry, vol. 9, no. 9, p. 3246, 2011. https://doi.org/10.1039/c0ob00768d[2] F. Malavasi, S. Deaglio, A. Funaro, E. Ferrero, A. Horenstein, E. Ortolanet al., Evolution and function of the adp ribosyl cyclase/cd38 gene family in physiology and pathology, Physiological Reviews, vol. 88, no. 3, p. 841-886, 2008. https://doi.org/10.1152/physrev.00035.2007[3] E. Chini, C. Chini, J. Netto, G. Oliveira, & W. Schooten, The pharmacology of cd38/nadase: an emerging target in cancer and diseases of aging, Trends in Pharmacological Sciences, vol. 39, no. 4, p. 424-436, 2018. https://doi.org/10.1016/j.tips.2018.02.001[4] H. Higashida, S. Yokoyama, M. Kikuchi, & T. Munesue, Cd38 and its role in oxytocin secretion and social behavior, Hormones and Behavior, vol. 61, no. 3, p. 351-358, 2012. https://doi.org/10.1016/j.yhbeh.2011.12.011[5] V. Sathish, M. Thompson, S. Sinha, G. Sieck, Y. Prakash, & C. Pabelick, Inflammation, caveolae and cd38-mediated calcium regulation in human airway smooth muscle, Biochimica Et Biophysica Acta (Bba) - Molecular Cell Research, vol. 1843, no. 2, p. 346-351, 2014. https://doi.org/10.1016/j.bbamcr.2013.11.011[6] S. Amici, M. Young, J. Narvaez-Miranda, K. Jablonski, J. Arcos, L. Rosaset al., Cd38 is robustly induced in human macrophages and monocytes in inflammatory conditions, Frontiers in Immunology, vol. 9, 2018. https://doi.org/10.3389/fimmu.2018.01593[7] J. Mottahedeh, M. Haffner, T. Grogan, T. Hashimoto, P. Crowell, H. Beltranet al., Cd38 is methylated in prostate cancer and regulates extracellular nad+, Cancer & Metabolism, vol. 6, no. 1, 2018. https://doi.org/10.1186/s40170-018-0186-3

ACP03629

Recombinant human ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 (CD38) production in mammalian cells involves co-cloning the gene encoding the extracellular domain of the human CD38 protein (43-300aa) into an expression vector with a C-terminal hFc-tag gene, followed by transformation into mammalian cells. The cells are cultured under conditions that induce protein expression. After sufficient growth, the cells are lysed to release the recombinant protein. Purification is achieved using affinity chromatography technique. The purity of the CD38 protein is confirmed using SDS-PAGE, reaching over 85%.
Human CD38 protein is a transmembrane glycoprotein that stimulates B-lymphocyte activation and acts as an enzyme that catalyzes the synthesis of cyclic ADP-ribose from NAD+ [1]. It is a part of the ADP ribosyl cyclase/CD38 gene family and is evolutionarily conserved, indicating its importance in human physiology [2]. CD38 functions as an ectoenzyme and a receptor, degrading NAD and modulating cellular NAD homeostasis [3]. Furthermore, CD38 is involved in oxytocin secretion, social behavior, and calcium regulation [4][5]. It is expressed in inflammatory conditions and is robustly induced in human macrophages under inflammatory stimuli [6]. CD38 is also implicated in diseases like cancer, where it is methylated in prostate cancer and regulates extracellular NAD+ [7].
References:[1] M. Dong, Y. Qi, S. Sun, X. Pu, Z. Yang, L. Zhanget al., Design, synthesis and biological characterization of novel inhibitors of cd38, Organic & Biomolecular Chemistry, vol. 9, no. 9, p. 3246, 2011. https://doi.org/10.1039/c0ob00768d[2] F. Malavasi, S. Deaglio, A. Funaro, E. Ferrero, A. Horenstein, E. Ortolanet al., Evolution and function of the adp ribosyl cyclase/cd38 gene family in physiology and pathology, Physiological Reviews, vol. 88, no. 3, p. 841-886, 2008. https://doi.org/10.1152/physrev.00035.2007[3] E. Chini, C. Chini, J. Netto, G. Oliveira, & W. Schooten, The pharmacology of cd38/nadase: an emerging target in cancer and diseases of aging, Trends in Pharmacological Sciences, vol. 39, no. 4, p. 424-436, 2018. https://doi.org/10.1016/j.tips.2018.02.001[4] H. Higashida, S. Yokoyama, M. Kikuchi, & T. Munesue, Cd38 and its role in oxytocin secretion and social behavior, Hormones and Behavior, vol. 61, no. 3, p. 351-358, 2012. https://doi.org/10.1016/j.yhbeh.2011.12.011[5] V. Sathish, M. Thompson, S. Sinha, G. Sieck, Y. Prakash, & C. Pabelick, Inflammation, caveolae and cd38-mediated calcium regulation in human airway smooth muscle, Biochimica Et Biophysica Acta (Bba) – Molecular Cell Research, vol. 1843, no. 2, p. 346-351, 2014. https://doi.org/10.1016/j.bbamcr.2013.11.011[6] S. Amici, M. Young, J. Narvaez-Miranda, K. Jablonski, J. Arcos, L. Rosaset al., Cd38 is robustly induced in human macrophages and monocytes in inflammatory conditions, Frontiers in Immunology, vol. 9, 2018. https://doi.org/10.3389/fimmu.2018.01593[7] J. Mottahedeh, M. Haffner, T. Grogan, T. Hashimoto, P. Crowell, H. Beltranet al., Cd38 is methylated in prostate cancer and regulates extracellular nad+, Cancer & Metabolism, vol. 6, no. 1, 2018. https://doi.org/10.1186/s40170-018-0186-3

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP03629 Target NameCD38
FormLiquid or Lyophilized powderExpression SystemMammalian cell
Expression Range43-300aaMol Weight57.4 kDa
Protein LengthExtracellular DomainPurityGreater than 85% as determined by SDS-PAGE.
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDP28907
Background Information
  • Uniprot Id

    P28907

  • Target Species

    Human

  • Target Name

    CD38

  • Target Full Name

    ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1

  • Target Function

    Synthesizes the second messengers cyclic ADP-ribose and nicotinate-adenine dinucleotide phosphate, the former a second messenger for glucose-induced insulin secretion. Also has cADPr hydrolase activity. Also moonlights as a receptor in cells of the immune system.

  • Target Subcellular Location

    Membrane; Single-pass type II membrane protein.

  • Target Protein Families

    ADP-ribosyl cyclase family

  • Target Tissue Specificity

    Expressed at high levels in pancreas, liver, kidney, brain, testis, ovary, placenta, malignant lymphoma and neuroblastoma.

  • Target Research Area

    Cancer

  • Target Synonyms

    CD38; ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1; 2'-phospho-ADP-ribosyl cyclase; 2'-phospho-ADP-ribosyl cyclase/2'-phospho-cyclic-ADP-ribose transferase; 2'-phospho-cyclic-ADP-ribose transferase; ADP-ribosyl cyclase 1; ADPRC 1; Cyclic ADP-ribose hydrolase 1; cADPr hydrolase 1; T10; CD antigen CD38

  • Target Background

    The protein encoded by this gene is a non-lineage-restricted, type II transmembrane glycoprotein that synthesizes and hydrolyzes cyclic adenosine 5'-diphosphate-ribose, an intracellular calcium ion mobilizing messenger. The release of soluble protein and the ability of membrane-bound protein to become internalized indicate both extracellular and intracellular functions for the protein. This protein has an N-terminal cytoplasmic tail, a single membrane-spanning domain, and a C-terminal extracellular region with four N-glycosylation sites. Crystal structure analysis demonstrates that the functional molecule is a dimer, with the central portion containing the catalytic site. It is used as a prognostic marker for patients with chronic lymphocytic leukemia. Alternative splicing results in multiple transcript variants.

Inquire Recombinant Human ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 (CD38), Truncated Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification